Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Adolescent Health Literacy and Learning
$190.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.Towards Sustainable Fisheries Management: A Perspective of Fishing Technology Weaknesses and Opportunities with a Focus on the Mediterranean Fisheries
02.Current International Perspectives on Wildland Fires, Mankind and the Environment
03.Fukushima Nuclear Accident: Global Implications, Long-Term Health Effects and Ecological Consequences
04.Microbiological Clinical Hygiene
05.Botulinum Toxin in Dermatology: A Clinical Overview
06.Quality of Life in Endocrine Diseases
07.Prognostic and Predictive Response Therapy Factors in Cancer Disease (Colorectal, Breast, Liver, Lung, Gastric, Renal and Prostate Cancers)
08.Molecular Aspects of the Psychosomatic-Metabolic Axis and Stress
09.Increasing Student Achievement through Effective School Leadership: Practitioners’ Perspectives
10.Through the Eyes of a Learner: My Teacher’s Emotional Intelligence
11.Time, Life, and Civilization
12.Ulysses S. Grant: In The Interests of the Whole People

Nova Science Publishers
© Copyright 2004 - 2015

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266